doi: 10.1161/hh1601.095596
© 2001 American Heart Association, Inc.
Review |
Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque
From the Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY.
Correspondence to Zahi A. Fayad, PhD, Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, Box 1030, New York, NY 10029. E-mail zahi.fayad{at}mssm.edu
 |
Abstract |
|---|
 Top Abstract IntroductionAtherosclerotic Plaques and Need...Imaging of Atherosclerotic...ConclusionsReferences |
|---|
The study of atherosclerotic disease during its natural history and after therapeutic intervention will enhance our understanding of disease progression and regression and aid in selecting appropriate treatments. Several invasive and noninvasive imaging techniques are available to assess atherosclerotic vessels. Most of the standard techniques identify luminal diameter, stenosis, wall thickness, and plaque volume; however, none can characterize plaque composition and therefore identify the high-risk plaques. We will present the different imaging modalities that have been used for the direct assessment of the carotid, aortic, and coronary atherosclerotic plaques. We will review in detail the use of high-resolution, multicontrast magnetic resonance for the noninvasive imaging of vulnerable plaques and the characterization of plaques in terms of their various components (ie, lipid, fibrous, calcium, or thrombus).
Key Words: atherosclerosis • magnetic resonance imaging • ultrasound • computed tomography • lipid-lowering
|
Introduction |
|---|
|
TopAbstractIntroductionAtherosclerotic Plaques and Need...Imaging of Atherosclerotic...ConclusionsReferences |
|---|
Atherosclerosis is a systemic disease of the vessel wall that occurs in the aorta and in the carotid, coronary, and peripheral arteries.1 The main components of the atherosclerotic plaques are (1) connective tissue extracellular matrix, including collagen, proteoglycans, and fibronectin elastic fibers; (2) crystalline cholesterol, cholesteryl esters, and phospholipids; and (3) cells such as monocyte-derived macrophages, T lymphocytes, and smooth muscle cells.2 Varying proportions of these components occur in different plaques, thus giving rise to a spectrum of lesions.1,3,4
|
Atherosclerotic Plaques and Need for Imaging |
|---|
|
TopAbstractIntroductionAtherosclerotic Plaques and Need...Imaging of Atherosclerotic...ConclusionsReferences |
|---|
The high-risk or vulnerable plaque has different characteristics depending on the arterial regions (ie, coronaries, carotids, or aorta).
Coronary Artery Vulnerable Plaques
Rupture-prone plaques in the coronary arteries, the so-called "vulnerable plaques," tend to have a thin fibrous cap (cap thickness 
65 to 150 µm) and a large lipid core. Acute coronary syndromes (ACSs) often result from rupture of a modestly stenotic vulnerable plaque,3,4 not visible by x-ray angiography.3
According to the criteria of the American Heart Association Committee on Vascular Lesions, lesion types depend in part on the phase of progression as shown schematically in Figure 1.1,4 Coronary "vulnerable" type IV and type Va lesions (phase 2) and the "complicated" type VI lesions (phase 4) are the most relevant to ACS. Type IV and Va lesions, although not necessarily stenotic at angiography, are prone to disruption (see the Figure in the online data supplement available at http://www.circresaha.org), with macrophage-dependent release of proteolytic enzymes such as metalloproteinases.2,5 Type IV lesions consist of extracellular lipid intermixed with fibrous tissue covered by a fibrous cap, whereas type Va lesions possess a predominant extracellular lipid core covered by a thin fibrous cap. Disruption of a type IV or Va lesion leads to the formation of a thrombus or "complicated" type VI lesion. The lipid core is highly thrombogenic as a result of the presence of tissue factor.1,6 The type VI lesion associated in ACS, rather than being characterized by a small mural thrombus, consists of an occlusive thrombus.
|
Relatively small type IV and Va coronary lesions may account for as many as two-thirds of cases of unstable angina or other ACSs.3 These relatively nonstenotic plaques with large lipid cores are more vulnerable and at higher risk of rupture and thrombosis; the caps are often thinnest at the shoulder region where macrophages7 and mast cells8 accumulate and disruption tends to occur.5 In contrast, the most severely stenotic plaques at angiography, which have a high content of smooth muscle cells and collagen, and little lipid, are less susceptible to rupture.
Carotid Artery High-Risk Plaques
In contrast to coronary artery vulnerable plaques characterized by high lipid content and a thin fibrous cap, high-risk plaques in carotid arteries are severely stenotic. The term "high-risk" is used rather than the classic term "vulnerable," which only implies the presence of a lipid-rich core. High-risk carotid plaques are heterogeneous, very fibrous, and not necessarily lipid-rich. Rupture often represents an intramural hematoma or dissection, probably related to the impact of blood during systole against the resistance of such stenotic lesion.9 Imaging and plaque characterization of carotid arteries are simpler than those of coronary arteries because the former are superficial and not subject to significant motion.10 This is also true for the assessment of lower-extremity atherosclerotic disease, in which the pathobiology is similar to that of carotid disease. However, compared with peripheral vascular lesions, more information about carotid plaques and their imaging is available.
Aortic Vulnerable Plaques
Postmortem11 and transesophageal echocardiography (TEE)12 studies have shown that thoracic aortic atherosclerosis is a significant marker for coronary artery disease (CAD).13 Parameters such as aortic wall thickness, luminal irregularities, and plaque composition are strong predictors of future vascular events.14,15 Using TEE, the French Aortic Plaque in Stroke investigators determined increased risk of all vascular events (stroke, myocardial infarction, peripheral embolism, and cardiovascular death) for patients who had noncalcified aortic plaques >4 mm thick.14,15 Such noncalcified plaques, relatively easy to assess and characterize by imaging methods, are thought to be lipid-laden plaques (types IV/Va),15 which are prone to rupture and thrombosis in coronary arteries.
|
Imaging of Atherosclerotic Plaques |
|---|
|
TopAbstractIntroductionAtherosclerotic Plaques and Need...Imaging of Atherosclerotic...ConclusionsReferences |
|---|
Direct visualization of plaques may enhance understanding of the natural history of atherosclerotic disease. Currently, a number of invasive and noninvasive imaging modalities are used to study atherosclerosis (Table 1); most identify luminal diameter or stenosis, wall thickness, and plaque volume.
|
Invasive Imaging
X-Ray Angiography
The x-ray angiogram reflects luminal diameter and provides a measure of stenosis with excellent resolution or irregular luminal surface implying the presence of atherosclerotic disease. But this imaging method does not image the vessel wall or provide information about the composition of the atherosclerotic plaque such as the vulnerable lipid-rich plaques or other histopathological features.16 This technique, however, has become the gold standard for diagnosis of coronary, carotid, and peripheral artery lesions. Nevertheless, angiography may reveal advanced lesions, plaque disruption, luminal thrombosis, and calcification. The degree of stenosis measures blood flow obstruction. Calculation of the stenosis depends on proper designation of a normal reference segment. One of the major limitations of angiography is that diffuse atherosclerotic disease may narrow the entire lumen of the artery, and as a result underestimate the degree of local stenosis. In addition, because some of the plaques may be displaced outward, the luminal diameter may appear normal despite significant disease.17
Intravascular Ultrasound (IVUS)
Ultrasound (US) imaging is based on transmitting and receiving high-frequency sound waves. The time between transmission and reception of the wave is directly related to the distance between the source and reflector.
Catheter-based US is a new approach to the arterial vascular wall imaging. This invasive modality permits direct and real-time imaging of atheroma and provides a cross-sectional, tomographic perspective of the vessel and atherosclerotic disease.18 Diagnostic applications of IVUS include detection of angiographically unrecognized disease, detection of lesions of uncertain severity (40% to 75% stenosis), and risk stratification of atherosclerotic lesions in interventional practice.
Current-generation catheters (incorporating a transducer) range in diameter from 0.96 to 1.17 mm and provide high-quality images. The spatial resolution is 100 to 250 µm (depending on the US probe frequency). On the basis of plaque echogenicity, coronary atheroma can be differentiated into three categories, as follows: (1) highly echoreflective regions with acoustic shadows, often corresponding to calcified tissue; (2) hyperechoic areas representing fibrosis or microcalcifications; or (3) hypoechoic regions corresponding to thrombotic or lipid-rich tissue or a mixture of these elements.18 IVUS can delineate the thickness and echogenicity of vessel wall structures; however, histopathological information is limited.18 Spectral information of the radiofrequency signal may facilitate the discrimination of atheroma.19 Angioscopy (described below) and histological studies generally report low sensitivity to IVUS in detection of thrombus and lipid-rich lesions.20
IVUS may be useful in selecting the most appropriate option of transcatheter therapy (rotational atherectomy, stents, etc).21 For example, lesions with calcification would be expected to be more rigid and, therefore, prone to rupture in response to the mechanical stress of balloon dilation, whereas softer, lipid-rich, noncalcified plaques may stretch but not fracture.22 Studies aimed at sensitivity and specificity involving large numbers of patients are required to determine the use of IVUS for the detection of atherosclerotic disease.18
Methods such as IVUS elastography have been introduced to assess mechanical properties of the vessel wall, which may relate indirectly to the histopathological composition of the atherosclerotic plaque.23 Intravascular elastography is obtained from cardiac-gated IVUS images coupled with intraluminal pressures during the cardiac cycle. The images provide vessel wall strain information and reflect mechanical properties of the tissue. A preliminary in vitro study demonstrated the successful discrimination of fibrous and lipid-rich plaques (Figure 2) using IVUS elastography.23 However, the in vivo application of IVUS elastography may be hampered by catheter motion during cardiac contraction.
|
Angioscopy
Intracoronary angioscopy allows direct visualization of the plaque surface, color of the luminal surface (red, white, or yellow), presence of thrombus, and macroscopic features (tears, ulcerations, and fissures).24 A recent clinical trial suggested a potential application of this invasive technique. In patients with various coronary syndromes, angiographic findings were directly compared with histomorphology and ex vivo angioscopy of atherectomized material.25 This study concluded that yellow (lipid-rich) plaques are associated with the development of ACSs. Another study concluded that angioscopic identification of plaque rupture and thrombus was independently associated with adverse outcome in patients with complex lesions after interventional procedures.26 These features were not identified by either angiography or IVUS. However, like IVUS, this technique is invasive. Angioscopy thus remains a research tool because of the inability to examine small-caliber vessels or cross-stenotic lesions, and the different layers within the arterial wall.
Thermography, Optical Coherence Tomography, Raman Spectroscopy, and Near-Infrared (NIR) Spectroscopy
Several new technologies for invasive atherosclerotic plaque detection may have diagnostic and therapeutic implications.
In vitro27 and in vivo28 studies illustrate that detection of heat released by activated inflammatory cells of atherosclerotic plaques may predict plaque disruption and thrombosis. A study using carotid endarterectomy specimens and a needle thermistor demonstrated that atherosclerotic plaques exhibit thermal heterogeneity on their luminal surface.27 Temperature differences correlated positively with cell (macrophage) density. A catheter-based technique for the temperature measurement of human coronary arteries in vivo has been developed.28 The system consists of a 3F catheter, with 0.05°C accuracy and a spatial resolution of 500 µm. Using this catheter, thermal heterogeneity was found to be larger in patients with unstable angina compared with those with acute myocardial infarction.28 Thermal techniques could conceivably be combined with IVUS or optical coherence tomography (see below) to provide both functional and anatomic information.
Optical coherence tomography is analogous to IVUS, but measures the intensity of reflected infrared light rather than acoustic waves.29 A Michelson interferometer is used as a gate to detect unscattered photons and thus generates high-resolution images. Although penetration is generally 1 to 2 mm, the use of light allows a resolutions of 10 to 30 µm. Initial in vitro imaging (resolution of 16 µm) of human aortic plaques demonstrated a strong correlation with the corresponding histopathology.29 In vitro optical coherence tomography exhibited superior delineation of structural detail when compared with IVUS.30 In vivo optical coherence tomography imaging, using a laser as light source, at four frames per second has been obtained in the rabbit esophagus.31 Potential limitations of optical coherence tomography for in vivo intravascular imaging are the possible reduction of image quality when imaging through blood or large volumes of tissue, relatively slow data acquisition rate, lack of an adequate portable source for in vivo imaging, and multiple scattering.32 Like IVUS, this technique is invasive, which may restrict its use in patients.
Raman spectroscopy is an optical technique that characterizes the chemical composition of biological tissue. Raman spectra can be obtained by processing the collected light that is scattered by a tissue as it is illuminated with a laser. Raman spectroscopy can be combined with other catheter-based imaging techniques, such as IVUS, to localize and quantify cholesterol and calcium salts in atherosclerotic plaques.33 Current limitations of Raman spectroscopy are the strong background fluorescence, the absorbance by blood of the laser light, and the relatively long acquisition time. Because this is a 1-dimentional technique (no depth information), it may be more powerful when combined with other imaging techniques.33
Infrared spectroscopy also yields information on the chemical composition of tissue. NIR spectroscopy (750 to 2500 nm) has the advantage of deep penetration.34 Recently, the use of NIR spectroscopy has been explored for the characterization of the composition of atherosclerotic lesions. A study showed a good correlation between NIR spectra and plaque composition by histology for formalin-fixed human atherosclerotic plaques.35 Another study used a small (2.5-mm diameter) fiberoptic catheter combined with NIR reflectance spectroscopy and detected cholesterol in the rabbit aorta.36 Similar to Raman spectroscopy, NIR may be combined with other catheter-based imaging techniques.
Noninvasive Imaging
Surface and Transesophageal US
Measurements of carotid and aortic wall thickness as well as qualitative and quantitative analysis of plaque can be determined by surface and transesophageal US. Echogenicity of the plaque reflects its characteristics. Hypoechoic heterogeneous plaque is associated with both intraplaque hemorrhage and lipids, whereas hyperechoic homogeneous plaque is mostly fibrous.15,18
The North American Symptomatic Carotid Endarterectomy Trial and the Asymptomatic Carotid Artery Stenosis Study have shown that the degree of stenosis and its hemodynamic consequences play a significant role in producing stroke.37,38 High-resolution (<0.4 mm axial), real-time B-mode US with Doppler flow imaging has emerged as the modality of choice for examining the carotid arteries.39
Using 
8-MHz transducers, B-mode US can be used for measuring intima-media thickness (IMT) of large- and medium-size peripheral arteries such as the carotid, femoral, or radial. Because of the physical principles of a diagnostic US, the measurement is reliable only at the far arterial wall and does not indicate whether the thickening is due to intima or media infiltration and/or hypertrophy.40 As with other US methods, this technique is operator-dependent and has low reproducibility.
Several studies have found that carotid and aortic atherosclerosis are markers for coronary atherosclerosis.13,41,42 Patients with symptomatic CAD have increased IMT compared with asymptomatic controls.43 Carotid wall thickening was also found in patients with silent ischemia.44 The relationship between IMT and CAD severity is constant but rather weak.45 Nevertheless, large prospective studies have demonstrated that IMT may be a useful marker of CAD progression. For example, the Cardiovascular Health Study found associations between carotid IMT and the incidence of new myocardial infarction or stroke in patients 65 years of age.41 Prevention trials of lipid-lowering treatments using IMT as a surrogate end point have shown that retardation in the progress of IMT correlates with a reduction of clinical end points.46,47
Studies also have shown an association between aortic plaque seen on chest x-ray and the subsequent development of clinical CAD.48 Examinations of the aorta by B-mode US49 and TEE50 have been used as predictors of CAD and cardiovascular risk.14 Using TEE, the French Aortic Plaque in Stroke group14,15 found a significantly increased risk of all vascular events for patients who had noncalcified aortic plaques >4 mm in thickness. TEE-detected aortic plaque has been correlated with a higher prevalence of CAD and the presence of significant angiographic coronary artery stenosis.13 In addition, the lack of aortic plaque on TEE has been shown to be predictive of the absence of CAD.51
Ultrasonic contrast agents have been introduced to improve image resolution and specificity.52–54 For example, acoustic liposomes conjugated with monoclonal antibodies can be used for plaque component–targeted imaging. The liposome formulation also has been modified to allow site-specific drug55 or gene56 delivery.
Ultrafast Computed Tomography (UFCT)
UFCT allows image acquisition at a faster rate than conventional computed tomography (CT). Fast imaging is essential elimination of cardiac and respiratory motion artifacts. Atherosclerotic calcification is found more frequently in advanced lesions, and may occur in small amounts in early lesions.57
Magnetic resonance imaging (MRI), x-ray angiography, and US can identify calcified deposits in blood vessels; however, only electron-beam CT (EBCT)58 and fast-gated helical or spiral CT59 can measure the amount or volume of calcium. In EBCT, x-ray radiation passes through the patient and is detected by two 240° detector rings. To measure coronary calcium, 30 to 40 contiguous, 3-mm-thick slices are obtained from the aortic root to the apex of the heart. The scans are usually acquired during one or two separate breath holds. Non-EBCT systems use a continuously rotating x-ray source. Recently, non-EBCT systems have been introduced, using multidetector arrays for short rotation times that improve imaging speed.60 For example, a 4-slice detector array system provides an 8-fold improved performance over single-slice CT system. Comparison of coronary calcium assessment by EBCT and non-EBCT systems demonstrated good correlation.59
Histological and UFCT studies support the association of tissue densities 130 Hounsfield units with calcified plaques.61 However, high-risk plaques often lack calcium.62 There is an association between coronary calcium and obstructive CAD, and it has been suggested that the amount of coronary calcium is a predictor of risk of coronary events.63 However, the predictive value of coronary calcification, at least in high-risk subjects, may not be superior to that of standard coronary risk factors.64 In addition, a high calcium score is sensitive but not a specific marker for coronary stenosis.65 The greatest potential for coronary calcium scores appears to be in the detection of advanced coronary atherosclerosis in patients who are apparently at intermediate risk. The new volumetric method for calcium detected the effect of lipid-lowering on coronary calcification.58 Nevertheless, there is no evidence to support that changes in coronary calcification may correspond to changes in cardiovascular events.64,66
UFCT angiography with intravenous injection of a contrast medium is widely used for detection of stenosis in peripheral vessels. With the advent of faster and higher-resolution imaging and soft-tissue delineation with UFCT, assessment of coronary stenosis60,67 and the detection of noncalcified coronary plaques68 are being explored.
Nuclear Scintigraphy
Many radiotracers have been developed on the basis of molecules and cells involved in atherogenesis.69 The potential diagnostic utility of such radiotracers for imaging atherosclerotic lesions has been examined in animal models and in humans.69 Many proteins labeled with radioiodine, 99mTc, 111In, or 125In were evaluated.70 These include lipoproteins (native LDL and oxidized LDL), immunoglobulins against macrophages, smooth muscle cells, and endothelial adhesion molecules.71,72 These tracers showed significant uptake in experimental atherosclerotic lesions, although the limited clinical trials could not demonstrate utility because of slower clearance of radiotracers from circulation and poor target/background ratios.73 Radiolabeled peptides74 and metabolic tracers such as fluorodeoxyglucose, which show faster clearance from circulation and appear to provide higher contrast than radiolabeled proteins, were recently introduced.70 Similarly, radiolabeled antifibrin antibody fragments and peptides (which bind to glycoprotein IIb/IIIa receptors on activated platelets) clear faster from circulation compared with radiolabeled platelets.75 A new glycoprotein IIb/IIIa platelet inhibitor, DMP-44, labeled with 99mTc accurately identifies the platelet-rich thrombus in a canine model.76 We recently illustrated that in vivo fluorodeoxyglucose positron emission tomography may detect and quantify macrophage content in rabbits with aortic plaques.77 However, no single radiotracer is ideally suited to image atherosclerosis and to provide the prognostic and clinical indicators necessary for medical and surgical interventions.69
Magnetic Resonance Imaging
High-resolution magnetic resonance (MR) has emerged as the potential leading noninvasive in vivo imaging modality for atherosclerotic plaque characterization. MR differentiates plaque components on the basis of biophysical and biochemical parameters such as chemical composition and concentration, water content, physical state, molecular motion, or diffusion. MR provides imaging without ionizing radiation and can be repeated sequentially over time.
High-resolution MR relies on the same principles as other MR techniques. During the examination, the patient is subjected to a high local magnetic field, usually 1.5 T, which aligns the protons in the body. These protons (or spins) are excited by a radiofrequency pulse and subsequently detected by receiver coils. Detected signals are influenced by the relaxation times (T1 and T2), proton density, motion and flow, molecular diffusion, magnetization transfer, changes in susceptibility, etc. Three additional magnetic fields (gradient fields) are applied during MRI; one selects the slice and two encodes spatial information. The timing of the excitation pulses and the successive magnetic field gradients determine the image contrast. The ability to obtain images of the atherosclerotic vessels is dependent on the amount of available signal, contrast, and the lack of noise.
The MR images can be "weighted" to the T1, T2, or proton density values through manipulation of the MR parameters (ie, repetition time and echo time). In a T1-weighted (T1W) image, tissues with low T1 values will be displayed as hyperintense picture elements or pixels (high signal intensity) and, conversely, high T1 values will be displayed as hypointense pixels (low signal intensity). In a T2-weighted (T2W) image, tissues with high T2 values will be portrayed as hyperintense pixels, and those with low T2 values as hypointense pixels. Thus, a T1W and a T2W image for the same anatomy can appear quite different because an MR image is not a photograph, but a computerized map of radio signals emitted by the human body. Finally, a proton density–weighted (PDW) image is an image in which the differences in contrast are proportional to the density of water and fat protons within the tissue. It is also referred to as an intermediate-weighted image because the contrast in the image is a combination of mild T1 and T2 contrast.
Ex Vivo MR Plaque Studies
Early work on applying MR techniques to characterizing plaque focused on lipid assessment with nuclear MR spectroscopy and chemical-shift imaging.78–80 These techniques suffer from poor signal-to-noise (SNR) ratio, because the concentration of the lipid present in the plaque is very low in comparison with water.81 Therefore, it has been difficult to extend these methods to an in vivo setting. Current studies are focused on MRI of water protons.
MR Multicontrast Plaque Imaging
After an ex vivo study,82 Herfkens et al83 performed the first in vivo patient imaging study of aortic atherosclerosis. Only the anatomic or morphological features such as wall thickening and luminal narrowing were assessed.
Improvements in MR techniques (eg, faster imaging and detection coils), conducive to high resolution and contrast imaging, have permitted the study of the different plaque components using multicontrast MR, generated by T1, T2, and PDW imaging.84 Atherosclerotic plaque characterization by MR is based on the signal intensities (Table 2) and morphological appearance of the plaque on T1W, PDW, and T2W images as previously validated.10,81,85–89
|
The plaque fibrous tissues consisting mainly of extracellular matrix elaborated by smooth muscle cells are associated with a short T1. The origin of the T1 shortening (increased signal intensity on T1W images) is specific to protein-water interactions.90 The plaque lipids consist primarily of unesterified cholesterol and cholesteryl esters and are associated with a short T2.81 The short T2 (decreased signal intensity of T2W images) of the lipid components is in part due to the micellar structure of lipoproteins, their denaturation by oxidation, or the exchange between cholesteryl esters and water molecules (both from the fatty chain or from the cholesterol ring), with a further interchange between free and bound water.81 Perivascular fat, mainly composed of triglycerides, has a different appearance on MR than atherosclerotic plaque lipids.91 The plaque-calcified regions consist primarily of calcium hydroxylapatite and are associated with low signal intensities on the MR images because of their low proton density and because of diffusion-mediated susceptibility effects.92 The MR appearance and evolution of thrombus or hemorrhage have been investigated in the central nervous system,93 pelvis,94 and aorta.95 These studies showed that the different MR signal intensities of hemorrhage depend on the structure of hemoglobin and its oxidation state.93 Additional studies in the context of arterial thrombus and atherosclerosis are necessary.
In a recent study, we analyzed 22 human carotid endarterectomy specimens with ex vivo MR and histopathological examination.96 Cross-sections were matched between the multicontrast MR images and histopathology. The overall sensitivity and specificity for each component were very high. Calcification, fibrous tissue, lipid core, and thrombus were readily identified. Diffusion imaging, which probes the motion of the water molecules, facilitated thrombus detection.97
In Vivo MRI Experimental Studies
MR has been used in the study of plaques in several animal models.98 Skinner et al99 induced aortic plaque in the rabbit through a combination of atherogenic diet and double-balloon denudation, which showed in vivo aortic plaque progression. In a similar rabbit model, we validated the ability of MRI to quantify lipid-rich and fibrous components of lesions.89 Fast-spin echo multicontrast sequences with in-plane resolution of 0.35 mm and slice thickness of 3 mm were obtained. We have asserted that aortic MR atherosclerotic imaging can be used as a tool for documentation of arterial remodeling in the rabbit model.100 Two separate MRI serial studies101,102 have shown a significant regression of the aortic plaque in vivo in atherosclerotic rabbits undergoing cholesterol lowering. A significant correlation was found between MR and histopathology for atherosclerotic burden and plaque composition.102
Another serial MRI study on the effect of lipid-lowering therapy with 3-hydroxy-3-methylglutaryl–coenzyme A (CoA) reductase inhibitors (statins) and a novel class of agents, acyl-CoA:cholesterol O-acyltransferase (ACAT) inhibitors showed the beneficial effects in a Watanabe rabbit.103 The combination of statins and ACAT inhibitors induced a significant regression of previously established atherosclerotic lesions.
Using conventional MR systems (ie, 1.5 T), an in-plane spatial resolution 300 µm can be achieved with a high SNR and contrast-to-noise ratio for in vivo vessel wall imaging. To study small structures, such as the abdominal aorta of mice (<1 mm in luminal diameter), it is necessary to increase the SNR by using high magnetic field scanners equipped with small radiofrequency coils and strong magnetic field gradients.104 Using a 9.4-T (89-mm-bore system), we studied in vivo atherosclerosis in live animals.104 The achieved spatial resolution with MR microscopy (MRM) was 50 to 97 µm in-plane and 500 µm in slice thickness. Using transgenic apolipoprotein E knockout mice, we showed an excellent agreement between MRM and histological findings for aortic plaque size, shape, and characteristics (Figure 3). We also followed the rapid progression of atherosclerosis in animals with lesions of varying severity.105 Therefore, high-resolution MRI and MRM may allow convenient and noninvasive quantitative assessment of serial changes in atherosclerosis in different animal models of disease progression and regression.98
|
In Vivo MRI Studies on Human Carotid Artery Plaque
MR has been used for the study of atherosclerotic plaque in the human carotid,10,106 aortic,107 peripheral,108 and coronary109 arterial disease. In vivo images of advanced lesions in carotid arteries have been obtained from patients referred for endarterectomy.10 The superficial location and relative absence of motion of carotid arteries present less of a technical challenge for imaging than does the aorta or coronary arteries. Short T2 components were quantified in vivo before surgery and correlated with values obtained in vitro after surgery.10 Some of the MR studies of carotid arterial plaques include the imaging and characterization of normal and pathological arterial walls,10 the quantification of plaque size,106 and the detection of fibrous cap "integrity."110 Typically the images are acquired with resolution of 0.4x0.4x3 mm3 using a carotid phased-array coil.
Most of the in vivo MR plaque imaging and characterization have been performed using a multicontrast approach with high-resolution black-blood spin echo– and fast spin echo– based MR sequences. The signal from the blood flow is rendered black by the use of preparatory pulses (eg, radiofrequency spatial saturation or inversion recovery pulses) to better visualize the adjacent vessel wall. Hatsukami et al110 introduced the use of bright blood imaging (ie, 3-dimensional fast time-of-flight imaging) for the visualization of the fibrous cap thickness and morphological integrity. This sequence provides enhancement of the signal from flowing blood and a mixture of T1 and proton density contrast weighting that highlights the fibrous cap.
MR angiography (MRA) and high-resolution black-blood imaging of the vessel wall can be combined (Figure 4). Comparison studies of MRA and contrast angiography have shown good sensitivity and specificity in the aorta and in the carotid, renal, and other peripheral vessels.111 MRA demonstrates the severity of stenotic lesions and their spatial distribution, whereas the high-resolution black-blood wall characterization technique may show the composition of the plaques and may facilitate the risk stratification and selection of the treatment modality. Improvements in spatial resolution (250 µm) have been possible with the design of new phased-array coils112,113 tailored for carotid imaging114 and new imaging sequences such as long echo train fast spin echo imaging with "velocity-selective" flow suppression or double-inversion recovery preparatory pulses (black-blood imaging).107,109
|
In Vivo MRI Studies on Human Aortic Plaque
In vivo black-blood MR atherosclerotic plaque characterization of the human aorta has been reported recently.107,115 The principal challenges associated with MRI of the thoracic aorta are obtaining sufficient sensitivity for submillimeter imaging and exclusion of artifacts caused by respiratory motion and blood flow. Summers et al115 showed by MRI that the wall thickness of the ascending aorta is increased in patients with homozygous familial hypercholesterolemia. However, conventional T1W spin echo images were obtained and no plaque composition analysis was performed.115 Fayad et al107 assessed thoracic aorta plaque composition and size using T1W, T2W, and PDW images. The acquired images had a resolution of 0.8x0.8x5 mm3 using a torso phased-array coil. Rapid high-resolution imaging was performed with a fast spin echo sequence in conjunction with velocity-selective flow suppression preparatory pulses. Matched cross-sectional aortic imaging with MR and TEE showed a strong correlation for plaque composition and mean maximum plaque thickness. A patient with a lipid-rich plaque in the descending aorta is shown in Figure 5.
|
A recent study using MR in asymptomatic subjects from the Framingham Heart Study demonstrated that aortic plaque burden (ie, plaque volume/aortic volume) increased significantly with age, and was higher in the abdominal aorta compared with the thoracic aorta.116 Results ascertained that long-term measures of risk factors and Framingham Heart Study coronary risk score are strongly associated with asymptomatic aortic atherosclerosis as detected by MR.117
In Vivo MRI Studies on Coronary Artery Plaque
Preliminary studies in a pig model proclaimed that the difficulties of coronary wall imaging are due to the combination of cardiac and respiratory motion artifacts, nonlinear course, small size, and location of the coronary arteries.88,118 We extended the black-blood MR methods used in the human carotid artery and aorta for imaging of the coronary arterial lumen and wall.109 The method was validated in swine coronary lesions induced by balloon angioplasty.118 The intraobserver and interobserver variability assessment by intraclass correlation for both MRI and histopathology showed good reproducibility, with the intraclass correlation coefficients ranging from 0.96 to 0.99. MRI was also able to visualize intralesion hematoma (sensitivity 82%, specificity 84%).
High-resolution black-blood MR of both normal and atherosclerotic human coronary arteries was performed. The difference in maximum wall thickness between the normal subjects and patients (40% stenosis) was statistically significant. Figure 6 shows an in vivo MR image of a patient with a plaque in the left anterior descending coronary artery. The coronary MR plaque imaging study by Fayad et al109 was performed during breath-holding to minimize respiratory motion. To alleviate the need for breath-holding, Botnar et al119 have combined the black-blood fast spin echo method and a real-time navigator for respiratory gating and real-time slice–position correction.
|
In Vivo Monitoring of Therapy With MRI
As shown in experimental studies, MR is a powerful tool to investigate serially and noninvasively the progression and regression of atherosclerotic lesions in vivo. We have shown recently that MR can be used to measure the effect of lipid-lowering therapy (statins) in asymptomatic untreated hypercholesterolemic patients with carotid and aortic atherosclerosis.120 Atherosclerotic plaques were assessed with MR at different time points after initiation of lipid-lowering therapy. Significant regression of atherosclerotic lesions was observed. Despite the early and expected hypolipidemic effect of the statins, a minimum of 12 months was needed to observe changes in the vessel wall. No changes were detected at 6 months. In agreement with previous experimental studies, there was a decrease in the vessel wall area and no change in the lumen area at 12 months.101,103
MR of the popliteal artery and its response to balloon angioplasty has been reported by Coulden et al.108 The extent of plaque could be defined in all patients, such that even in segments of vessel that were angiographically normal, atherosclerotic lesions with cross-sectional areas ranging from 49% to 76% of potential lumen area were identified. After angioplasty, plaque fissuring, and local dissection were easily detected and serial changes in lumen diameter, blood flow, and lesion size were documented. This study illustrated that MR can define the extent of atherosclerotic plaque in the peripheral vasculature and demonstrate the remodeling and restenosis after angioplasty.
Limitations and Potential Improvements of MRI
Thinner slices such as those obtained with 3-dimensional acquisition techniques could further improve artery wall imaging.121 Tailored coil designs, such as smaller anterior 4-element phased-array coils, may enhance the spatial resolution and may allow the identification of the substructures within coronary atherosclerotic lesions.113 Additional MR techniques such as water diffusion weighting,96,97 magnetization transfer weighting,122 and contrast enhancement123,124 may provide complementary structural information and allow more detailed plaque characterization. Slowly flowing blood near the vessel walls is another phenomenon that may potentially improve the accuracy of vessel wall imaging with black-blood techniques. Preliminary results in our study and with a similar black blood–MR sequence in the coronary arteries and the brain109,118 suggest that this effect is minimal. However, new and more robust blood-suppression methods are needed for accurate plaque imaging especially in the carotid artery bifurcation.125
|
Conclusions |
|---|
|
TopAbstractIntroductionAtherosclerotic Plaques and Need...Imaging of Atherosclerotic...ConclusionsReferences |
|---|
Assessment of atherosclerotic plaques by imaging techniques is essential for in vivo identification of vulnerable plaques. Several invasive and noninvasive imaging techniques are available. Most techniques identify luminal diameter or stenosis, wall thickness, and plaque volume, and are ineffective in identifying the high-risk plaques that are vulnerable to rupture and thrombosis. In vivo, high-resolution, multicontrast MRI holds the best promise of noninvasively imaging high-risk plaques. MR allows serial assessment of progression and regression of atherosclerosis. Application of MRI opens new areas for diagnosis, prevention, and treatment (eg, lipid-lowering drug regimens) of atherosclerosis in all arterial locations.
|
Acknowledgments |
|---|
This work was supported in part by grants from the Radiological Society of North America; New York Community Trust; National Heart, Lung, and Blood Institute Grants P50-HL-54469, R01-HL-61801, and R01-HL-61814; and by funds from Merck, General Electric Medical Systems, and the Cardiovascular Institute and Department of Radiology. We thank Drs Roberto Corti, John T. Fallon, and Ernane Reis and Bob Guerra and Victoria Wei.
Received February 26, 2001; accepted July 6, 2001.
|
References |
|---|
|
TopAbstractIntroductionAtherosclerotic Plaques and Need...Imaging of Atherosclerotic...ConclusionsReferences |
|---|
1. Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: biology. Lancet. . 1999; 353 (suppl 2): SII5–SII9.
2.
Libby P. Molecular bases of the acute coronary syndromes. Circulation. . 1995; 91: 2844–2850.
3.
Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. . 1995; 92: 657–671.
4.
Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. . 1994; 90: 2126–2146.
5. Richardson PD, Davies MJ, Born GV. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. . 1989; 2: 941–944.[Medline] [Order article via Infotrieve]
6.
Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. . 1997; 95: 594–599.
7.
Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. . 1994; 90: 775–778.
8.
Kaartinen M, Penttila A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. . 1994; 90: 1669–1678.
9. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med. . 1988; 112: 1018–1031.[Medline] [Order article via Infotrieve]
10.
Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. . 1996; 94: 932–938.
11.
Solberg LA, Strong JP. Risk factors and atherosclerotic lesions: a review of autopsy studies. Arteriosclerosis. . 1983; 3: 187–198.
12.
Tunick PA, Kronzon I. Atheromas of the thoracic aorta: clinical and therapeutic update. J Am Coll Cardiol. . 2000; 35: 545–554.
13. Fazio GP, Redberg RF, Winslow T, Schiller NB. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol. . 1993; 21: 144–150.[Abstract]
14.
The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. . 1996; 334: 1216–1221.
15.
Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser MG, Amarenco P. Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation. . 1997; 96: 3838–3841.
16.
Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. . 1995; 92: 2333–2342.
17. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. . 1987; 316: 1371–1375.[Abstract]
18.
Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation. . 2001; 103: 604–616.
19. Bridal SL, Fornes P, Bruneval P, Berger G. Correlation of ultrasonic attenuation (30 to 50 MHz) and constituents of atherosclerotic plaque. Ultrasound Med Biol. . 1997; 23: 691–703.[Medline] [Order article via Infotrieve]
20. Franzen D, Sechtem U, Hopp HW. Comparison of angioscopic, intravascular ultrasonic, and angiographic detection of thrombus in coronary stenosis. Am J Cardiol. 1998;82:1273–1275, A9.
21. Fitzgerald PJ, Yock PG. Mechanisms and outcomes of angioplasty and atherectomy assessed by intravascular ultrasound imaging. J Clin Ultrasound. . 1993; 21: 579–588.[Medline] [Order article via Infotrieve]
22.
Lee RT, Grodzinsky AJ, Frank EH, Kamm RD, Schoen FJ. Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation. . 1991; 83: 1764–1770.
23.
de Korte CL, Pasterkamp G, van der Steen AF, Woutman HA, Bom N. Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro. Circulation. . 2000; 102: 617–623.
24. Uchida Y, Nakamura F, Tomaru T, Morita T, Oshima T, Sasaki T, Morizuki S, Hirose J. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J. . 1995; 130: 195–203.[Medline] [Order article via Infotrieve]
25. Thieme T, Wernecke KD, Meyer R, Brandenstein E, Habedank D, Hinz A, Felix SB, Baumann G, Kleber FX. Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol. . 1996; 28: 1–6.[Abstract]
26. Feld S, Ganim M, Carell ES, Kjellgren O, Kirkeeide RL, Vaughn WK, Kelly R, McGhie AI, Kramer N, Loyd D, Anderson HV, Schroth G, Smalling RW. Comparison of angioscopy, intravascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high risk patients. J Am Coll Cardiol. . 1996; 28: 97–105.[Abstract]
27. Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. . 1996; 347: 1447–1451.[Medline] [Order article via Infotrieve]
28.
Stefanadis C, Diamantopoulos L, Vlachopoulos C, Tsiamis E, Dernellis J, Toutouzas K, Stefanadi E, Toutouzas P. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation. . 1999; 99: 1965–1971.
29.
Brezinski ME, Tearney GJ, Bouma BE, Izatt JA, Hee MR, Swanson EA, Southern JF, Fujimoto JG. Optical coherence tomography for optical biopsy: properties and demonstration of vascular pathology. Circulation. . 1996; 93: 1206–1213.
30. Patwari P, Weissman NJ, Boppart SA, Jesser C, Stamper D, Fujimoto JG, Brezinski ME. Assessment of coronary plaque with optical coherence tomography and high-frequency ultrasound. Am J Cardiol. . 2000; 85: 641–644.[Medline] [Order article via Infotrieve]
31.
Tearney GJ, Brezinski ME, Bouma BE, Boppart SA, Pitris C, Southern JF, Fujimoto JG. In vivo endoscopic optical biopsy with optical coherence tomography. Science. . 1997; 276: 2037–2039.
32.
Fujimoto JG, Boppart SA, Tearney GJ, Bouma BE, Pitris C, Brezinski ME. High resolution in vivo intra-arterial imaging with optical coherence tomography. Heart. . 1999; 82: 128–133.
33.
Romer TJ, Brennan JF 3rd, Puppels GJ, Zwinderman AH, van Duinen SG, van der Laarse A, van der Steen AF, Bom NA, Bruschke AV. Intravascular ultrasound combined with Raman spectroscopy to localize and quantify cholesterol and calcium salts in atherosclerotic coronary arteries. Arterioscler Thromb Vasc Biol. . 2000; 20: 478–483.
34. Zhu Q, Conant E, Chance B. Optical imaging as an adjunct to sonograph in differentiating benign from malignant breast lesions. J Biomed Opt. . 2000; 5: 229–236.[Medline] [Order article via Infotrieve]
35. Moreno PR, Lodder RA, O’Connor WN, Muller JE. Characterization of composition and vulnerability of atherosclerotic plaques by near-infrared spectroscopy. Circulation. . 1998; 98 (suppl I): I-146. Abstract.
36. Charash WE, Lodder RA, Moreno PR, Purushothaman RK, Swain JA, O’Connor WN, Muller JE. Detection of simulated vulnerable plaque using a novel infrared spectroscopy catheter. J Am Coll Cardiol. . 2000; 35: 38A. Abstract.
37.
Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. . 1998; 339: 1415–1425.
38.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid stenosis. JAMA. . 1995; 273: 1421–1428.
39. Weinberger J, Ramos L, Ambrose JA, Fuster V. Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real time B-mode ultrasonography. J Am Coll Cardiol. . 1988; 12: 1515–1521.[Abstract]
40.
Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. . 1986; 74: 1399–1406.
41.
O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr . Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. . 1999; 340: 14–22.
42. Khoury Z, Schwartz R, Gottlieb S, Chenzbraun A, Stern S, Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol. . 1997; 80: 1429–1433.[Medline] [Order article via Infotrieve]
43.
Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke. . 1995; 26: 386–391.
44.
Nagai Y, Metter EJ, Earley CJ, Kemper MK, Becker LC, Lakatta EG, Fleg JL. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation. . 1998; 98: 1504–1509.
45.
Crouse JR 3rd, Craven TE, Hagaman AP, Bond MG. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation. . 1995; 92: 1141–1147.
46.
Salonen R, Nyyssonen K, Porkkala E, Rummukainen J, Belder R, Park JS, Salonen JT. Kuopio Atherosclerosis Prevention Study (KAPS): a population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation. . 1995; 92: 1758–1764.
47.
de Groot E, Jukema JW, Montauban van Swijndregt AD, Zwinderman AH, Ackerstaff RG, van der Steen AF, Bom N, Lie KI, Bruschke AV. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol. . 1998; 31: 1561–1567.
48. Witteman JC, Kannel WB, Wolf PA, Grobbee DE, Hofman A, D’Agostino RB, Cobb JC. Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol. . 1990; 66: 1060–1064.[Medline] [Order article via Infotrieve]
49.
Weinberger J, Azhar S, Danisi F, Hayes R, Goldman M. A new noninvasive technique for imaging atherosclerotic plaque in the aortic arch of stroke patients by transcutaneous real-time B-mode ultrasonography: an initial report. Stroke. . 1998; 29: 673–676.
50.
Tunick PA, Krinsky GA, Lee VS, Kronzon I. Diagnostic imaging of thoracic aortic atherosclerosis. AJR Am J Roentgenol. . 2000; 174: 1119–1125.
51. Parthenakis F, Skalidis E, Simantirakis E, Kounali D, Vardas P, Nihoyannopoulos P. Absence of atherosclerotic lesions in the thoracic aorta indicates absence of significant coronary artery disease. Am J Cardiol. . 1996; 77: 1118–1121.[Medline] [Order article via Infotrieve]
52.
Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ, Wickline SA. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. . 1996; 94: 3334–3340.
53.
Demos SM, Alkan-Onyuksel H, Kane BJ, Ramani K, Nagaraj A, Greene R, Klegerman M, McPherson DD. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol. . 1999; 33: 867–875.
54.
Lindner JR, Song J, Xu F, Klibanov AL, Singbartl K, Ley K, Kaul S. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation. . 2000; 102: 2745–2750.
55. Tiukinhoy SD, Huang S, Khan AA, MacDonald RC, McPherson DD. Novel acoustic drug-encapsulated liposomes for site-specific delivery. J Am Coll Cardiol. . 2001; 37: 256A. Abstract.
56. Tiukinhoy SD, Mahowald ME, Shively VP, Nagaraj A, Kane BJ, Klegerman ME, MacDonald RC, McPherson DD, Matsumura JS. Development of echogenic, plasmid-incorporated, tissue-targeted cationic liposomes that can be used for directed gene delivery. Invest Radiol. . 2000; 35: 732–738.[Medline] [Order article via Infotrieve]
57.
Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Writing Group. Circulation. . 1996; 94: 1175–1192.
58.
Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med. . 1998; 339: 1972–1978.
59.
Becker CR, Kleffel T, Crispin A, Knez A, Young J, Schoepf UJ, Haberl R, Reiser MF. Coronary artery calcium measurement: agreement of multirow detector and electron beam CT. AJR Am J Roentgenol. . 2001; 176: 1295–1298.
60.
Ohnesorge B, Flohr T, Becker C, Kopp AF, Schoepf UJ, Baum U, Knez A, Klingenbeck-Regn K, Reiser MF. Cardiac imaging by means of electrocardiographically gated multisection spiral CT: initial experience. Radiology. . 2000; 217: 564–571.
61.
Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation. . 1995; 92: 2157–2162.
62. Moreno PR, Raman Purushothaman K, O’Connor WN, Fuster V, Muller JE. Lack of association between calcification and vulnerability in human atherosclerotic plaques. J Am Coll Cardiol. . 2000; 35: 303A. Abstract.
63.
Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, Zelinger A, Mahmarian JJ. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. . 2000; 101: 850–855.
64.
O’Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL Jr, Forrester JS, Douglas PS, Faxon DP, Fisher JD, Gregoratos G, Hochman JS, Hutter AM Jr, Kaul S, Wolk MJ. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation. . 2000; 102: 126–140.
65.
Bielak LF, Kaufmann RB, Moll PP, McCollough CH, Schwartz RS, Sheedy PF 2nd . Small lesions in the heart identified at electron beam CT: calcification or noise? Radiology. . 1994; 192: 631–636.
66.
Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse JR 3rd, Friedman L, Fuster V, Herrington DM, Kuller LH, Ridker PM, Roberts WC, Stanford W, Stone N, Swan HJ, Taubert KA, Wexler L. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. . 2000; 101: e16–e22.
67.
Achenbach S, Moshage W, Ropers D, Nossen J, Daniel WG. Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary-artery stenoses and occlusions. N Engl J Med. . 1998; 339: 1964–1971.
68.
Becker CR, Knez A, Ohnesorge B, Schoepf UJ, Reiser MF. Imaging of noncalcified coronary plaques using helical CT with retrospective ECG gating. AJR Am J Roentgenol. . 2000; 175: 423–424.
69. Vallabhajosula S. Radioisotopic imaging of atheroma. In: Fuster V, ed. The Vulnerable Atherosclerotic Plaque: Understanding, Identification, and Modification. Armonk, NY: Futura Publishing; 1999: 213–229.
70.
Vallabhajosula S, Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med. . 1997; 38: 1788–1796.
71.
Vallabhajosula S, Paidi M, Badimon JJ, Le NA, Goldsmith SJ, Fuster V, Ginsberg HN. Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99 m low density lipoprotein versus radioiodinated low density lipoprotein preparations. J Nucl Med. . 1988; 29: 1237–1245.
72.
Iuliano L, Mauriello A, Sbarigia E, Spagnoli LG, Violi F. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: effect of vitamin E supplementation. Circulation. . 2000; 101: 1249–1254.
73.
Loscalzo J, Rocco TP. Imaging arterial thrombi: an elusive goal. Circulation. . 1992; 85: 382–385.
74. Hardoff R, Braegelmann F, Zanzonico P, Herrold EM, Lees RS, Lees AM, Dean RT, Lister-James J, Borer JS. External imaging of atherosclerosis in rabbits using an 123I-labeled synthetic peptide fragment. J Clin Pharmacol. . 1993; 33: 1039–1047.[Abstract]
75. Blum JE, Handmaker H. Plenary session: Friday imaging symposium: role of small-peptide radiopharmaceuticals in the evaluation of deep venous thrombosis. Radiographics. 2000;1999:20:1187–1193.
76.
Mitchel J, Waters D, Lai T, White M, Alberghini T, Salloum A, Knibbs D, Li D, Heller GV. Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99 m DMP-444: a canine model. Circulation. . 2000; 101: 1643–1646.
77. Helft G, Worthley SG, Zhang ZY, Tang C, Rodriguez O, Wei T, Fallon JT, Fayad ZA, Mahac J, Buchsbaum M, Fuster V, Badimon JJ. Non-invasive in vivo imaging of atherosclerotic lesions using fluorine-18 deoxyglucose (18-FDG) PET correlates with macrophage content in a rabbit model. Circulation. . 1999; 100 (suppl I): I-311. Abstract.
78. Pearlman JD, Zajicek J, Merickel MB, Carman CS, Ayers CR, Brookeman JR, Brown MF. High-resolution 1H NMR spectral signature from human atheroma. Magn Reson Med. . 1988; 7: 262–279.[Medline] [Order article via Infotrieve]
79.
Mohiaddin RH, Firmin DN, Underwood SR, Abdulla AK, Klipstein RH, Rees RS, Longmore DB. Chemical shift magnetic resonance imaging of human atheroma. Br Heart J. . 1989; 62: 81–89.
80.
Toussaint JF, Southern JF, Fuster V, Kantor HL. 13C-NMR spectroscopy of human atherosclerotic lesions: relation between fatty acid saturation, cholesteryl ester content, and luminal obstruction. Arterioscler Thromb. . 1994; 14: 1951–1957.
81. Toussaint JF, Southern JF, Fuster V, Kantor HL. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol. . 1995; 15: 1533–1542.
82. Kaufman L, Crooks LE, Sheldon PE, Rowan W, Miller T. Evaluation of NMR imaging for detection and quantification of obstructions in vessels. Invest Radiol. . 1982; 17: 554–560.[Medline] [Order article via Infotrieve]
83.
Herfkens RJ, Higgins CB, Hricak H, Lipton MJ, Crooks LE, Sheldon PE, Kaufman L. Nuclear magnetic resonance imaging of atherosclerotic disease. Radiology. . 1983; 148: 161–166.
84. Fayad ZA, Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann NY Acad Sci. . 2000; 902: 173–186.[Medline] [Order article via Infotrieve]
85. Merickel MB, Carman CS, Brookeman JR, Mugler JP, Brown MF, Ayers CR. Identification and 3-D quantification of atherosclerosis using magnetic resonance imaging. Comput Biol Med. . 1988; 18: 89–102.[Medline] [Order article via Infotrieve]
86. Martin AJ, Gotlieb AI, Henkelman RM. High-resolution MR imaging of human arteries. J Magn Reson Imaging. . 1995; 5: 93–100.[Medline] [Order article via Infotrieve]
87. von Ingersleben G, Schmiedl UP, Hatsukami TS, Nelson JA, Subramaniam DS, Ferguson MS, Yuan C. Characterization of atherosclerotic plaques at the carotid bifurcation: correlation of high-resolution MR imaging with histologic analysis: preliminary study. Radiographics. . 1997; 17: 1417–1423.[Abstract]
88. Worthley SG, Helft G, Fuster V, Fayad ZA, Fallon JT, Osende JI, Roque M, Shinnar M, Zaman AG, Rodriguez OJ, Verhallen P, Badimon JJ. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis. . 2000; 150: 321–329.[Medline] [Order article via Infotrieve]
89.
Helft G, Worthley SG, Fuster V, Zaman AG, Schechter C, Osende J, Rodriguez OJ, Fayad ZA, Fallon JT, Badimon JJ. Atherosclerotic aortic component quantification by noninvasive magnetic resonance: an in vivo study in rabbits. J Am Coll Cardiol. . 2001; 37: 1149–1154.
90. Edzes HT, Samulski ET. Cross relaxation and spin diffusion in the proton NMR or hydrated collagen. Nature. . 1977; 265: 521–523.[Medline] [Order article via Infotrieve]
91. Rapp JH, Connor WE, Lin DS, Inahara T, Porter JM. Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression. J Lipid Res. . 1983; 24: 1329–1335.[Abstract]
92. Kucharczyk W, Henkelman RM. Visibility of calcium on MR and CT: can MR show calcium that CT cannot? AJNR Am J Neuroradiol. 1994;15:1145–1148.
93.
Bradley WG Jr. MR appearance of hemorrhage in the brain. Radiology. . 1993; 189: 15–26.
94.
Yamashita Y, Hatanaka Y, Torashima M, Takahashi M. Magnetic resonance characteristics of intrapelvic haematomas. Br J Radiol. . 1995; 68: 979–985.
95.
Murray JG, Manisali M, Flamm SD, VanDyke CW, Lieber ML, Lytle BW, White RD. Intramural hematoma of the thoracic aorta: MR image findings and their prognostic implications. Radiology. . 1997; 204: 349–355.
96.
Shinnar M, Fallon JT, Wehrli S, Levin M, Dalmacy D, Fayad ZA, Badimon JJ, Harrington M, Harrington E, Fuster V. The diagnostic accuracy of ex vivo magnetic resonance imaging for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol. . 1999; 19: 2756–2761.
97.
Toussaint JF, Southern JF, Fuster V, Kantor HL. Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance. Arterioscler Thromb Vasc Biol. . 1997; 17: 542–546.
98.
Pohost GM, Fuisz AR. From the microscope to the clinic: MR assessment of atherosclerotic plaque. Circulation. . 1998; 98: 1477–1478.
99. Skinner MP, Yuan C, Mitsumori L, Hayes CE, Raines EW, Nelson JA, Ross R. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med. . 1995; 1: 69–73.[Medline] [Order article via Infotrieve]
100.
Worthley SG, Helft G, Fuster V, Zaman AG, Fayad ZA, Fallon JT, Badimon JJ. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation. . 2000; 101: 586–589.
101.
McConnell MV, Aikawa M, Maier SE, Ganz P, Libby P, Lee RT. MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol. . 1999; 19: 1956–1959.
102. Worthley SG, Helft G, Fuster V, Fayad ZA, Zaman AG, Fallon JT, Badimon JJ. Serial noninvasive in vivo MRI monitors progression and regression of individual atherosclerotic lesions in a rabbit model. J Am Coll Cardiol. . 2000; 35: 432A. Abstract.
103. Worthley SG, Helft G, Osende JI, Corti R, Fayad ZA, Fallon JT, Zaman AG, Fuster V, Badimon JJ. Serial evaluation of atherosclerosis with in vivo MRI: study of atorvastatin and avasimibe in WHHL rabbits. Circulation. . 2000; 102 (suppl II): II-809. Abstract.
104.
Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, Badimon JJ, Charlton SA, Fisher EA, Breslow JL, Fuster V. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. . 1998; 98: 1541–1547.
105. Aguinaldo JGS, Choudhury RP, Rong JX, Yodice C, Fallon JT, Fisher EA, Fayad ZA. Severity of atherosclerotic lesions in ApoE-/- mice assessed by non-invasive in vivo high resolution magnetic resonance microscopy. Circulation. . 2000; 102 (suppl II): II-459. Abstract.
106.
Yuan C, Beach KW, Smith LH Jr, Hatsukami TS. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. . 1998; 98: 2666–2671.
107.
Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, Shinnar M, Chesebro JH, Fuster V. In vivo MR evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with TEE. Circulation. . 2000; 101: 2503–2509.
108.
Coulden RA, Moss H, Graves MJ, Lomas DJ, Appleton DS, Weissberg PL. High resolution magnetic resonance imaging of atherosclerosis and the response to balloon angioplasty. Heart. . 2000; 83: 188–191.
109.
Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, Aguinaldo JG, Badimon JJ, Sharma SK. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. . 2000; 102: 506–510.
110.
Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation. . 2000; 102: 959–964.
111.
Yucel EK, Anderson CM, Edelman RR, Grist TM, Baum RA, Manning WJ, Culebras A, Pearce W. AHA scientific statement: magnetic resonance angiography: update on applications for extracranial arteries. Circulation. . 1999; 100: 2284–2301.
112. Fayad ZA, Connick TJ, Axel L. An improved quadrature or phased-array coil for MR cardiac imaging. Magn Reson Med. . 1995; 34: 186–193.[Medline] [Order article via Infotrieve]
113. Fayad ZA, Hardy CJ, Giaquinto R, Kini A, Sharma S. Improved high resolution MRI of human coronary lumen and plaque with a new cardiac coil. Circulation. . 2000; 102 (suppl II): II-399. Abstract.
114. Hayes CE, Mathis CM, Yuan C. Surface coil phased arrays for high-resolution imaging of the carotid arteries. J Magn Reson Imaging. . 1996; 6: 109–112.[Medline] [Order article via Infotrieve]
115.
Summers RM, Andrasko-Bourgeois J, Feuerstein IM, Hill SC, Jones EC, Busse MK, Wise B, Bove KE, Rishforth BA, Tucker E, Spray TL, Hoeg JM. Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia. Circulation. . 1998; 98: 509–518.
116. Jaffer FA, O’Donnell CJ, Kissinger KV, Chan SK, Botnar RM, Edelman RR, Manning WJ. MRI assessment of aortic atherosclerosis in an asymptomatic population: the Framingham Heart Study. Circulation. . 2000; 102 (suppl II): II-458. Abstract.
117. O’Donnell CJ, Larson MG, Jaffer FA, Kissinger KV, Levy D, Manning WJ. Aortic atherosclerosis detected by MRI is associated with contemporaneous and longitudinal risk factors: the Framingham Heart Study (FHS). Circulation. . 2000; 102 (suppl II): II-836. Abstract.
118.
Worthley SG, Helft G, Fuster V, Fayad ZA, Rodriguez OJ, Zaman AG, Fallon JT, Badimon JJ. Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation. . 2000; 101: 2956–2961.
119.
Botnar RM, Stuber M, Kissinger KV, Kim WY, Spuentrup E, Manning WJ. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation. . 2000; 102: 2582–2587.
120.
Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation. . 2001; 104: 249–252.
121. Luk-Pat GT, Gold GE, Olcott EW, Hu BS, Nishimura DG. High-resolution three-dimensional in vivo imaging of atherosclerotic plaque. Magn Reson Med. . 1999; 42: 762–771.[Medline] [Order article via Infotrieve]
122. Pachot-Clouard M, Vaufrey F, Darrasse L, Toussainti JF. Magnetization transfer characteristics in atherosclerotic plaque components assessed by adapted binomial preparation pulses. MAGMA. . 1998; 7: 9–15.
123. Lin W, Abendschein DR, Haacke EM. Contrast-enhanced magnetic resonance angiography of carotid arterial wall in pigs. J Magn Reson Imaging. . 1997; 7: 183–190.[Medline] [Order article via Infotrieve]
124. Yu X, Song SK, Chen J, Scott MJ, Fuhrhop RJ, Hall CS, Gaffney PJ, Wickline SA, Lanza GM. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med. . 2000; 44: 867–872.[Medline] [Order article via Infotrieve]
125. Steinman DA, Rutt BK. On the nature and reduction of plaque-mimicking flow artifacts in black blood MRI of the carotid bifurcation. Magn Reson Med. . 1998; 39: 635–641.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  T. Ibrahim, M. R. Makowski, A. Jankauskas, D. Maintz, M. Karch, S. Schachoff, W. J. Manning, A. Schomig, M. Schwaiger, and R. M. Botnar Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 580 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Amirbekian, J. G. S. Aguinaldo, S. Amirbekian, F. Hyafil, E. Vucic, M. Sirol, D. B. Weinreb, S. Le Greneur, E. Lancelot, C. Corot, et al. Atherosclerosis and Matrix Metalloproteinases: Experimental Molecular MR Imaging in Vivo Radiology, May 1, 2009; 251(2): 429 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. I. Lobbes, R.-J. J. H. M. Miserus, S. Heeneman, V. Lima Passos, P. H. A. Mutsaers, N. Debernardi, B. Misselwitz, M. Post, M. J. A. P. Daemen, J. M. A. van Engelshoven, et al. Atherosclerosis: Contrast-enhanced MR Imaging of Vessel Wall in Rabbit Model--Comparison of Gadofosveset and Gadopentetate Dimeglumine Radiology, March 1, 2009; 250(3): 682 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Doiron, K. Chu, A. Ali, and L. Brannon-Peppas Nanomaterials in Medicine Special Feature Sackler Colloquium: Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI PNAS, November 11, 2008; 105(45): 17232 - 17237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Beaussier, I. Masson, C. Collin, E. Bozec, B. Laloux, D. Calvet, M. Zidi, P. Boutouyrie, and S. Laurent Carotid Plaque, Arterial Stiffness Gradient, and Remodeling in Hypertension Hypertension, October 1, 2008; 52(4): 729 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nahrendorf, H. Zhang, S. Hembrador, P. Panizzi, D. E. Sosnovik, E. Aikawa, P. Libby, F. K. Swirski, and R. Weissleder Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis Circulation, January 22, 2008; 117(3): 379 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Christodoulou, S. Sangle, and D. P. D'Cruz Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome Rheumatology, June 1, 2007; 46(6): 907 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yanai, H. Yoshida, Y. Tomono, and N. Tada Atherosclerosis imaging in statin intervention trials QJM, May 1, 2007; 100(5): 253 - 262. [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-W. Wu, H.-L. Kao, M.-F. Chen, B.-C. Lee, W.-Y. I. Tseng, J.-S. Jeng, K.-Y. Tzen, R.-F. Yen, P.-J. Huang, and W.-S. Yang Characterization of Plaques Using 18F-FDG PET/CT in Patients with Carotid Atherosclerosis and Correlation with Matrix Metalloproteinase-1 J. Nucl. Med., February 1, 2007; 48(2): 227 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Pessanha, K. Potter, F. D. Kolodgie, A. Farb, R. Kutys, E. K. Mont, A. P. Burke, T. J. O'Leary, and R. Virmani Characterization of Intimal Changes in Coronary Artery Specimens with MR Microscopy Radiology, October 1, 2006; 241(1): 107 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Elesber, C. A. Conover, A. E. Denktas, R. J. Lennon, D. R. Holmes Jr, M. T. Overgaard, M. Christiansen, C. Oxvig, L. O. Lerman, and A. Lerman Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina Eur. Heart J., July 2, 2006; 27(14): 1678 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. N. Djaiani Aortic arch atheroma: stroke reduction in cardiac surgical patients. Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2006; 10(2): 143 - 157. [Abstract] [PDF]
|
|
|
|
|
|
R. Hosokawa, N. Kambara, M. Ohba, T. Mukai, M. Ogawa, H. Motomura, N. Kume, H. Saji, T. Kita, and R. Nohara A Catheter-Based Intravascular Radiation Detector of Vulnerable Plaques J. Nucl. Med., May 1, 2006; 47(5): 863 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Muller, A. Tawakol, S. Kathiresan, and J. Narula New opportunities for identification and reduction of coronary risk treatment of vulnerable patients, arteries, and plaques. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C2 - C6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Braunwald Epilogue: What Do Clinicians Expect From Imagers? J. Am. Coll. Cardiol., April 18, 2006; 47(8S): C101 - C103. [Full Text] [PDF]
|
|
|
|
|
|
F. A. Jaffer, P. Libby, and R. Weissleder Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1328 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A.G. Van Mieghem, E. P. McFadden, P. J. de Feyter, N. Bruining, J. A. Schaar, N. R. Mollet, F. Cademartiri, D. Goedhart, S. de Winter, G. R. Granillo, et al. Noninvasive Detection of Subclinical Coronary Atherosclerosis Coupled With Assessment of Changes in Plaque Characteristics Using Novel Invasive Imaging Modalities: The Integrated Biomarker and Imaging Study (IBIS) J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1134 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Valgimigli, G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, P. Malagutti, E. Regar, P. de Jaegere, P. de Feyter, and P. W. Serruys Distance from the ostium as an independent determinant of coronary plaque composition in vivo: an intravascular ultrasound study based radiofrequency data analysis in humans Eur. Heart J., March 2, 2006; 27(6): 655 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Ruberg, J. Viereck, A. Phinikaridou, Y. Qiao, J. Loscalzo, and J. A. Hamilton Identification of cholesteryl esters in human carotid atherosclerosis by ex vivo image-guided proton MRS J. Lipid Res., February 1, 2006; 47(2): 310 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Clarke, V. Beletsky, R. R. Hammond, R. A. Hegele, and B. K. Rutt Validation of Automatically Classified Magnetic Resonance Images for Carotid Plaque Compositional Analysis Stroke, January 1, 2006; 37(1): 93 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, Z. A. Fayad, P. R. Moreno, M. Poon, R. Corti, and J. J. Badimon Atherothrombosis and High-Risk Plaque: Part II: Approaches by Noninvasive Computed Tomographic/Magnetic Resonance Imaging J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1209 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Wolf, S. L. Wehrli, A. M. Popescu, J. H. Woo, H. K. Song, A. C. Wright, E. R. Mohler III, J. D. Harding, E. L. Zager, R. M. Fairman, et al. Mineral Volume and Morphology in Carotid Plaque Specimens Using High-Resolution MRI and CT Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1729 - 1735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Corti, V. Fuster, Z. A. Fayad, S. G. Worthley, G. Helft, W. F. Chaplin, J. Muntwyler, J. F. Viles-Gonzalez, J. Weinberger, D. A. Smith, et al. Effects of Aggressive Versus Conventional Lipid-Lowering Therapy by Simvastatin on Human Atherosclerotic Lesions: A Prospective, Randomized, Double-Blind Trial With High-Resolution Magnetic Resonance Imaging J. Am. Coll. Cardiol., July 5, 2005; 46(1): 106 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster and R. J. Kim Frontiers in Cardiovascular Magnetic Resonance Circulation, July 5, 2005; 112(1): 135 - 144. [Full Text] [PDF]
|
|
|
|
|
|
P. Libby Act Local, Act Global: Inflammation and the Multiplicity of "Vulnerable" Coronary Plaques J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1600 - 1602. [Full Text] [PDF]
|
|
|
|
|
|
V. C. Cappendijk, K. B. J. M. Cleutjens, A. G. H. Kessels, S. Heeneman, G. W. H. Schurink, R. J. T. J. Welten, W. H. Mess, M. J. A. P. Daemen, J. M. A. van Engelshoven, and M. E. Kooi Assessment of Human Atherosclerotic Carotid Plaque Components with Multisequence MR Imaging: Initial Experience Radiology, February 1, 2005; 234(2): 487 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wiesmann, S. E. Petersen, P. M. Leeson, J. M. Francis, M. D. Robson, Q. Wang, R. Choudhury, K. M. Channon, and S. Neubauer Global impairment of brachial, carotid, and aortic vascular function in young smokers: Direct quantification by high-resolution magnetic resonance imaging J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2056 - 2064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wyttenbach, A. Gallino, M. Alerci, F. Mahler, L. Cozzi, M. Di Valentino, J. J. Badimon, V. Fuster, and R. Corti Effects of Percutaneous Transluminal Angioplasty and Endovascular Brachytherapy on Vascular Remodeling of Human Femoropopliteal Artery by Noninvasive Magnetic Resonance Imaging Circulation, August 31, 2004; 110(9): 1156 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Wang, S.-L. T. Normand, L. Mauri, and R. E. Kuntz Coronary Artery Spatial Distribution of Acute Myocardial Infarction Occlusions Circulation, July 20, 2004; 110(3): 278 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schoenhagen, S. S. Halliburton, A. E. Stillman, S. A. Kuzmiak, S. E. Nissen, E. M. Tuzcu, and R. D. White Noninvasive Imaging of Coronary Arteries: Current and Future Role of Multi-Detector Row CT Radiology, July 1, 2004; 232(1): 7 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Mani, V. V. Itskovich, M. Szimtenings, J. G. S. Aguinaldo, D. D. Samber, G. Mizsei, and Z. A. Fayad Rapid Extended Coverage Simultaneous Multisection Black-Blood Vessel Wall MR Imaging Radiology, July 1, 2004; 232(1): 281 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.E. Nissen Identifying patients at risk: novel diagnostic techniques Eur. Heart J. Suppl., July 1, 2004; 6(suppl_C): C15 - C20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A Schaar, J. E Muller, E. Falk, R. Virmani, V. Fuster, P. W Serruys, A. Colombo, C. Stefanadis, S Ward Casscells, P. R Moreno, et al. Terminology for high-risk and vulnerable coronary artery plaques Eur. Heart J., June 2, 2004; 25(12): 1077 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Willerson and P. M. Ridker Inflammation as a Cardiovascular Risk Factor Circulation, June 1, 2004; 109(21_suppl_1): II-2 - II-10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Kramer, L. A. Cerilli, K. Hagspiel, J. M. DiMaria, F. H. Epstein, and J. A. Kern Magnetic Resonance Imaging Identifies the Fibrous Cap in Atherosclerotic Abdominal Aortic Aneurysm Circulation, March 2, 2004; 109(8): 1016 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kroger Dyslipoproteinemia and Peripheral Arterial Occlusive Disease Angiology, March 1, 2004; 55(2): 135 - 138. [Abstract] [PDF]
|
|
|
|
|
|
S. Verheye, G. R.Y. De Meyer, R. Krams, M. M. Kockx, L. C.A. Van Damme, B. M. Gourabi, M. W.M. Knaapen, G. Van Langenhove, and P. W. Serruys Intravascular thermography: Immediate functional and morphological vascular findings Eur. Heart J., January 2, 2004; 25(2): 158 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tatsumi, C. Cohade, Y. Nakamoto, and R. L. Wahl Fluorodeoxyglucose Uptake in the Aortic Wall at PET/CT: Possible Finding for Active Atherosclerosis Radiology, December 1, 2003; 229(3): 831 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Naghavi, P. Libby, E. Falk, S. W. Casscells, S. Litovsky, J. Rumberger, J. J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, et al. From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I Circulation, October 7, 2003; 108(14): 1664 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schoenhagen, G. W. Stone, S. E. Nissen, C. L. Grines, J. Griffin, B. S. Clemson, D. G. Vince, K. Ziada, T. Crowe, C. Apperson-Hanson, et al. Coronary Plaque Morphology and Frequency of Ulceration Distant From Culprit Lesions in Patients With Unstable and Stable Presentation Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1895 - 1900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Pannu, T. G. Flohr, F. M. Corl, and E. K. Fishman Current Concepts in Multi-Detector Row CT Evaluation of the Coronary Arteries: Principles, Techniques, and Anatomy RadioGraphics, October 1, 2003; 23(90001): S111 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Tuzcu and P. Schoenhagen Acute coronary syndromes, plaque vulnerability,and carotid artery disease: The changing role ofatherosclerosis imaging J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1033 - 1036. [Full Text] [PDF]
|
|
|
|
|
|
J. Barkhausen, W. Ebert, C. Heyer, J. F. Debatin, and H.-J. Weinmann Detection of Atherosclerotic Plaque With Gadofluorine-Enhanced Magnetic Resonance Imaging Circulation, August 5, 2003; 108(5): 605 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Redberg, R. A. Vogel, M. H. Criqui, D. M. Herrington, J. A. C. Lima, and M. J. Roman Task force #3--what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1886 - 1898. [Full Text] [PDF]
|
|
|
|
|
|
M.E. Kooi, V.C. Cappendijk, K.B.J.M. Cleutjens, A.G.H. Kessels, P.J.E.H.M. Kitslaar, M. Borgers, P.M. Frederik, M.J.A.P. Daemen, and J.M.A. van Engelshoven Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging Circulation, May 20, 2003; 107(19): 2453 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Vlachoyiannopoulos, P. G. Kanellopoulos, J. P. A. Ioannidis, M. G. Tektonidou, I. Mastorakou, and H. M. Moutsopoulos Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study Rheumatology, May 1, 2003; 42(5): 645 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Oberhoff and K. R Karsch Who wants his plaque sealed? Eur. Heart J., March 2, 2003; 24(6): 494 - 495. [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Schoen and R. F. Padera Jr. Cardiac Surgical Pathology Card. Surg. Adult, January 1, 2003; 2(2003): 119 - 185. [Full Text]
|
|
|
|
|
|
G. J. Blake, R. J. Ostfeld, E. K. Yucel, N. Varo, U. Schonbeck, M. A. Blake, M. Gerhard, P. M. Ridker, P. Libby, and R. T. Lee Soluble CD40 Ligand Levels Indicate Lipid Accumulation in Carotid Atheroma: An In Vivo Study With High-Resolution MRI Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): e11 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nair, B. D. Kuban, E. M. Tuzcu, P. Schoenhagen, S. E. Nissen, and D. G. Vince Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis Circulation, October 22, 2002; 106(17): 2200 - 2206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. A. Fayad, V. Fuster, K. Nikolaou, and C. Becker Computed Tomography and Magnetic Resonance Imaging for Noninvasive Coronary Angiography and Plaque Imaging: Current and Potential Future Concepts Circulation, October 8, 2002; 106(15): 2026 - 2034. [Full Text] [PDF]
|
|
|
|
|
|
V.S. Srinivas, M. M. Brooks, K. M. Detre, S. B. King III, A. K. Jacobs, J. Johnston, and D. O. Williams Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease: A Comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) Study Circulation, September 24, 2002; 106(13): 1627 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schoenhagen, E. M. Tuzcu, and S. G. Ellis Plaque Vulnerability, Plaque Rupture, and Acute Coronary Syndromes: (Multi)-Focal Manifestation of a Systemic Disease Process Circulation, August 13, 2002; 106(7): 760 - 762. [Full Text] [PDF]
|
|
|
|
|
|
R. P. Choudhury, V. Fuster, J. J. Badimon, E. A. Fisher, and Z. A. Fayad MRI and Characterization of Atherosclerotic Plaque: Emerging Applications and Molecular Imaging Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1065 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Corti, J. I. Osende, Z. A. Fayad, J. T. Fallon, V. Fuster, G. Mizsei, E. Dickstein, B. Drayer, and J. J. Badimon In vivo noninvasive detection and age definition of arterial thrombus by MRI J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1366 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yuan, S.-x. Zhang, N. L. Polissar, D. Echelard, G. Ortiz, J. W. Davis, E. Ellington, M. S. Ferguson, and T. S. Hatsukami Identification of Fibrous Cap Rupture With Magnetic Resonance Imaging Is Highly Associated With Recent Transient Ischemic Attack or Stroke Circulation, January 15, 2002; 105(2): 181 - 185. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||